Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 196 entries
Sorted by: Best Match Show Resources per page
Standards for medical student interviewing using ISIE-81 interaction analysis.

Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education

Templeton B, Roeske NC, MacDonald MZ, Clair D, Pellow T, Green L.
PMID: 3454587
Res Med Educ. 1987;26:222-7.

No abstract available.

Cite
Templeton B, Roeske NC, MacDonald MZ, et al. Standards for medical student interviewing using ISIE-81 interaction analysis. Res Med Educ. 1987;26:222-7
Templeton, B., Roeske, N. C., MacDonald, M. Z., Clair, D., Pellow, T., & Green, L. (1987). Standards for medical student interviewing using ISIE-81 interaction analysis. Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education, 26222-7.
Templeton, B, et al. "Standards for medical student interviewing using ISIE-81 interaction analysis." Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education vol. 26 (1987): 222-7.
Templeton B, Roeske NC, MacDonald MZ, Clair D, Pellow T, Green L. Standards for medical student interviewing using ISIE-81 interaction analysis. Res Med Educ. 1987;26:222-7. PMID: 3454587.
Copy Download .nbib Format: NLM
Loperamide Will Stop You Up but It Can Also Bring You Down: Answers to the January 2017 Journal Club questions.

Annals of emergency medicine

Bellew S, Barrett TW.
PMID: 28545698
Ann Emerg Med. 2017 Jun;69(6):786-791. doi: 10.1016/j.annemergmed.2017.02.007.

No abstract available.

Cite
Bellew S, Barrett TW. Loperamide Will Stop You Up but It Can Also Bring You Down: Answers to the January 2017 Journal Club questions. Ann Emerg Med. 2017;69(6):786-791doi: 10.1016/j.annemergmed.2017.02.007.
Bellew, S., & Barrett, T. W. (2017). Loperamide Will Stop You Up but It Can Also Bring You Down: Answers to the January 2017 Journal Club questions. Annals of emergency medicine, 69(6), 786-791. https://doi.org/10.1016/j.annemergmed.2017.02.007
Bellew, Shawna, and Barrett, Tyler W. "Loperamide Will Stop You Up but It Can Also Bring You Down: Answers to the January 2017 Journal Club questions." Annals of emergency medicine vol. 69,6 (2017): 786-791. doi: https://doi.org/10.1016/j.annemergmed.2017.02.007
Bellew S, Barrett TW. Loperamide Will Stop You Up but It Can Also Bring You Down: Answers to the January 2017 Journal Club questions. Ann Emerg Med. 2017 Jun;69(6):786-791. doi: 10.1016/j.annemergmed.2017.02.007. PMID: 28545698.
Copy Download .nbib Format: NLM
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains.

ACS medicinal chemistry letters

Taylor AM, Vaswani RG, Gehling VS, Hewitt MC, Leblanc Y, Audia JE, Bellon S, Cummings RT, Côté A, Harmange JC, Jayaram H, Joshi S, Lora JM, Mertz JA, Neiss A, Pardo E, Nasveschuk CG, Poy F, Sandy P, Setser JW, Sims RJ, Tang Y, Albrecht BK.
PMID: 26985289
ACS Med Chem Lett. 2015 Mar 25;7(2):145-50. doi: 10.1021/ml500411h. eCollection 2016 Feb 11.

Inhibition of the bromodomains of the BET family, of which BRD4 is a member, has been shown to decrease myc and interleukin (IL) 6 in vivo, markers that are of therapeutic relevance to cancer and inflammatory disease, respectively. Herein...

Cite
Taylor AM, Vaswani RG, Gehling VS, et al. Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains. ACS Med Chem Lett. 2015;7(2):145-50doi: 10.1021/ml500411h.
Taylor, A. M., Vaswani, R. G., Gehling, V. S., Hewitt, M. C., Leblanc, Y., Audia, J. E., Bellon, S., Cummings, R. T., Côté, A., Harmange, J. C., Jayaram, H., Joshi, S., Lora, J. M., Mertz, J. A., Neiss, A., Pardo, E., Nasveschuk, C. G., Poy, F., Sandy, P., Setser, J. W., Sims, R. J., Tang, Y., & Albrecht, B. K. (2016). Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains. ACS medicinal chemistry letters, 7(2), 145-50. https://doi.org/10.1021/ml500411h
Taylor, Alexander M, et al. "Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains." ACS medicinal chemistry letters vol. 7,2 (2016): 145-50. doi: https://doi.org/10.1021/ml500411h
Taylor AM, Vaswani RG, Gehling VS, Hewitt MC, Leblanc Y, Audia JE, Bellon S, Cummings RT, Côté A, Harmange JC, Jayaram H, Joshi S, Lora JM, Mertz JA, Neiss A, Pardo E, Nasveschuk CG, Poy F, Sandy P, Setser JW, Sims RJ, Tang Y, Albrecht BK. Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains. ACS Med Chem Lett. 2015 Mar 25;7(2):145-50. doi: 10.1021/ml500411h. eCollection 2016 Feb 11. PMID: 26985289; PMCID: PMC4753545.
Copy Download .nbib Format: NLM
VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis.

Molecular & cellular oncology

Karali E, Bellou S, Stellas D, Klinakis A, Murphy C, Fotsis T.
PMID: 27308350
Mol Cell Oncol. 2014 Dec 23;1(3):e964024. doi: 10.4161/23723548.2014.964024. eCollection 2014.

Vascular endothelial growth factor (VEGF) activates unfolded protein response sensors in the endoplasmic reticulum through phospholipase C gamma (PLCγ)-mediated crosstalk with mammalian target of rapamycin complex 1 (mTORC1). Activation of transcription factor 6 (ATF6) and protein kinase RNA-like endoplasmic...

Cite
Karali E, Bellou S, Stellas D, et al. VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis. Mol Cell Oncol. 2014;1(3):e964024doi: 10.4161/23723548.2014.964024.
Karali, E., Bellou, S., Stellas, D., Klinakis, A., Murphy, C., & Fotsis, T. (2014). VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis. Molecular & cellular oncology, 1(3), e964024. https://doi.org/10.4161/23723548.2014.964024
Karali, Evdoxia, et al. "VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis." Molecular & cellular oncology vol. 1,3 (2014): e964024. doi: https://doi.org/10.4161/23723548.2014.964024
Karali E, Bellou S, Stellas D, Klinakis A, Murphy C, Fotsis T. VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis. Mol Cell Oncol. 2014 Dec 23;1(3):e964024. doi: 10.4161/23723548.2014.964024. eCollection 2014. PMID: 27308350; PMCID: PMC4904886.
Copy Download .nbib Format: NLM
IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.

Clinical molecular pathology

Zumkeller W, Mahmood A, Dellow R, Schofield PN.
PMID: 16696034
Clin Mol Pathol. 1995 Dec;48(6):M333-41. doi: 10.1136/mp.48.6.m333.

Aims-To determine the role of insulin-like growth factors (IGF) in the proliferation of tumour cells, by studying the mitogenic response to IGFs of three cell lines of differing phenotype established from both malignant rhabdoid and Wilms tumour, representing a...

Cite
Zumkeller W, Mahmood A, Dellow R, et al. IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood. Clin Mol Pathol. 1995;48(6):M333-41doi: 10.1136/mp.48.6.m333.
Zumkeller, W., Mahmood, A., Dellow, R., & Schofield, P. N. (1995). IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood. Clinical molecular pathology, 48(6), M333-41. https://doi.org/10.1136/mp.48.6.m333
Zumkeller, W, et al. "IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood." Clinical molecular pathology vol. 48,6 (1995): M333-41. doi: https://doi.org/10.1136/mp.48.6.m333
Zumkeller W, Mahmood A, Dellow R, Schofield PN. IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood. Clin Mol Pathol. 1995 Dec;48(6):M333-41. doi: 10.1136/mp.48.6.m333. PMID: 16696034; PMCID: PMC408001.
Copy Download .nbib Format: NLM
The Prophylactic Value of Scarlet Fever Antitoxin.

British medical journal

Harries EH, Hervey D, Fellowes V.
PMID: 20772553
Br Med J. 1926 May 22;1(3411):864-5. doi: 10.1136/bmj.1.3411.864.

No abstract available.

Cite
Harries EH, Hervey D, Fellowes V. The Prophylactic Value of Scarlet Fever Antitoxin. Br Med J. 1926;1(3411):864-5doi: 10.1136/bmj.1.3411.864.
Harries, E. H., Hervey, D., & Fellowes, V. (1926). The Prophylactic Value of Scarlet Fever Antitoxin. British medical journal, 1(3411), 864-5. https://doi.org/10.1136/bmj.1.3411.864
Harries, E H, et al. "The Prophylactic Value of Scarlet Fever Antitoxin." British medical journal vol. 1,3411 (1926): 864-5. doi: https://doi.org/10.1136/bmj.1.3411.864
Harries EH, Hervey D, Fellowes V. The Prophylactic Value of Scarlet Fever Antitoxin. Br Med J. 1926 May 22;1(3411):864-5. doi: 10.1136/bmj.1.3411.864. PMID: 20772553; PMCID: PMC2523847.
Copy Download .nbib Format: NLM
Temperature dependence of magnetoresistance oscillations in a two-dimensional electron gas subjected to a periodic potential.

Physical review. B, Condensed matter

Alves ES, Beaumont SP, Beton PH, Davison M, Dellow M, Eaves L, Main PC, Taylor RP, Wilkinson CD.
PMID: 9995210
Phys Rev B Condens Matter. 1990 Nov 15;42(15):9689-9692. doi: 10.1103/physrevb.42.9689.

No abstract available.

Cite
Alves ES, Beaumont SP, Beton PH, et al. Temperature dependence of magnetoresistance oscillations in a two-dimensional electron gas subjected to a periodic potential. Phys Rev B Condens Matter. 1990;42(15):9689-9692doi: 10.1103/physrevb.42.9689.
Alves, E. S., Beaumont, S. P., Beton, P. H., Davison, M., Dellow, M., Eaves, L., Main, P. C., Taylor, R. P., & Wilkinson, C. D. (1990). Temperature dependence of magnetoresistance oscillations in a two-dimensional electron gas subjected to a periodic potential. Physical review. B, Condensed matter, 42(15), 9689-9692. https://doi.org/10.1103/physrevb.42.9689
Alves, et al. "Temperature dependence of magnetoresistance oscillations in a two-dimensional electron gas subjected to a periodic potential." Physical review. B, Condensed matter vol. 42,15 (1990): 9689-9692. doi: https://doi.org/10.1103/physrevb.42.9689
Alves ES, Beaumont SP, Beton PH, Davison M, Dellow M, Eaves L, Main PC, Taylor RP, Wilkinson CD. Temperature dependence of magnetoresistance oscillations in a two-dimensional electron gas subjected to a periodic potential. Phys Rev B Condens Matter. 1990 Nov 15;42(15):9689-9692. doi: 10.1103/physrevb.42.9689. PMID: 9995210.
Copy Download .nbib Format: NLM
Intraosseous pressure during loading and with vascular occlusion in an animal model.

Bone & joint research

Beverly M, Mellon S, Kennedy JA, Murray DW.
PMID: 30258570
Bone Joint Res. 2018 Sep 15;7(8):511-516. doi: 10.1302/2046-3758.78.BJR-2017-0343.R2. eCollection 2018 Aug.

OBJECTIVES: We studied subchondral intraosseous pressure (IOP) in an animal model during loading, and with vascular occlusion. We explored bone compartmentalization by saline injection.MATERIALS AND METHODS: Needles were placed in the femoral condyle and proximal tibia of five anaesthetized...

Cite
Beverly M, Mellon S, Kennedy JA, et al. Intraosseous pressure during loading and with vascular occlusion in an animal model. Bone Joint Res. 2018;7(8):511-516doi: 10.1302/2046-3758.78.BJR-2017-0343.R2.
Beverly, M., Mellon, S., Kennedy, J. A., & Murray, D. W. (2018). Intraosseous pressure during loading and with vascular occlusion in an animal model. Bone & joint research, 7(8), 511-516. https://doi.org/10.1302/2046-3758.78.BJR-2017-0343.R2
Beverly, M, et al. "Intraosseous pressure during loading and with vascular occlusion in an animal model." Bone & joint research vol. 7,8 (2018): 511-516. doi: https://doi.org/10.1302/2046-3758.78.BJR-2017-0343.R2
Beverly M, Mellon S, Kennedy JA, Murray DW. Intraosseous pressure during loading and with vascular occlusion in an animal model. Bone Joint Res. 2018 Sep 15;7(8):511-516. doi: 10.1302/2046-3758.78.BJR-2017-0343.R2. eCollection 2018 Aug. PMID: 30258570; PMCID: PMC6138809.
Copy Download .nbib Format: NLM
Multimodal perceptual organization of speech: Evidence from tone analogs of spoken utterances.

Speech communication

Remez RE, Fellowes JM, Pisoni DB, Goh WD, Rubin PE.
PMID: 21423823
Speech Commun. 1998 Oct 01;26(1):65-73. doi: 10.1016/S0167-6393(98)00050-8.

Theoretical and practical motives alike have prompted recent investigations of multimodal speech perception. Theoretically, multimodal studies have extended the conceptualization of perceptual organization beyond the familiar modality-bound accounts deriving from Gestalt psychology. Practically, such investigations have been driven by...

Cite
Remez RE, Fellowes JM, Pisoni DB, et al. Multimodal perceptual organization of speech: Evidence from tone analogs of spoken utterances. Speech Commun. 1998;26(1):65-73doi: 10.1016/S0167-6393(98)00050-8.
Remez, R. E., Fellowes, J. M., Pisoni, D. B., Goh, W. D., & Rubin, P. E. (1998). Multimodal perceptual organization of speech: Evidence from tone analogs of spoken utterances. Speech communication, 26(1), 65-73. https://doi.org/10.1016/S0167-6393(98)00050-8
Remez, Robert E, et al. "Multimodal perceptual organization of speech: Evidence from tone analogs of spoken utterances." Speech communication vol. 26,1 (1998): 65-73. doi: https://doi.org/10.1016/S0167-6393(98)00050-8
Remez RE, Fellowes JM, Pisoni DB, Goh WD, Rubin PE. Multimodal perceptual organization of speech: Evidence from tone analogs of spoken utterances. Speech Commun. 1998 Oct 01;26(1):65-73. doi: 10.1016/S0167-6393(98)00050-8. PMID: 21423823; PMCID: PMC3060793.
Copy Download .nbib Format: NLM
Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery.

Tomography (Ann Arbor, Mich.)

Coolens C, Driscoll B, Foltz W, Pellow C, Menard C, Chung C.
PMID: 30042966
Tomography. 2016 Dec;2(4):325-333. doi: 10.18383/j.tom.2016.00178.

Dynamic contrast-enhanced (DCE)-MRI metrics are evaluated against volumetric DCE-CT quantitative parameters as a standard for tracer-kinetic validation using a common 4-dimensional temporal dynamic analysis platform in tumor perfusion measurements following stereotactic radiosurgery (SRS) for brain metastases. Patients treated with...

Cite
Coolens C, Driscoll B, Foltz W, et al. Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery. Tomography. 2016;2(4):325-333doi: 10.18383/j.tom.2016.00178.
Coolens, C., Driscoll, B., Foltz, W., Pellow, C., Menard, C., & Chung, C. (2016). Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery. Tomography (Ann Arbor, Mich.), 2(4), 325-333. https://doi.org/10.18383/j.tom.2016.00178
Coolens, Catherine, et al. "Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery." Tomography (Ann Arbor, Mich.) vol. 2,4 (2016): 325-333. doi: https://doi.org/10.18383/j.tom.2016.00178
Coolens C, Driscoll B, Foltz W, Pellow C, Menard C, Chung C. Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery. Tomography. 2016 Dec;2(4):325-333. doi: 10.18383/j.tom.2016.00178. PMID: 30042966; PMCID: PMC6037934.
Copy Download .nbib Format: NLM
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research

McLeod R, Kumar R, Papadatos-Pastos D, Mateo J, Brown JS, Garces AHI, Ruddle R, Decordova S, Jueliger S, Ferraldeschi R, Maiques O, Sanz-Moreno V, Jones P, Traub S, Halbert G, Mellor S, Swales KE, Raynaud FI, Garrett MD, Banerji U.
PMID: 32616501
Clin Cancer Res. 2020 Sep 15;26(18):4777-4784. doi: 10.1158/1078-0432.CCR-20-0700. Epub 2020 Jul 02.

PURPOSE: AT13148 is an oral AGC kinase inhibitor, which potently inhibits ROCK and AKT kinases. In preclinical models, AT13148 has been shown to have antimetastatic and antiproliferative activity.PATIENTS AND METHODS: The trial followed a rolling six design during dose...

Cite
McLeod R, Kumar R, Papadatos-Pastos D, et al. First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors. Clin Cancer Res. 2020;26(18):4777-4784doi: 10.1158/1078-0432.CCR-20-0700.
McLeod, R., Kumar, R., Papadatos-Pastos, D., Mateo, J., Brown, J. S., Garces, A. H. I., Ruddle, R., Decordova, S., Jueliger, S., Ferraldeschi, R., Maiques, O., Sanz-Moreno, V., Jones, P., Traub, S., Halbert, G., Mellor, S., Swales, K. E., Raynaud, F. I., Garrett, M. D., & Banerji, U. (2020). First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(18), 4777-4784. https://doi.org/10.1158/1078-0432.CCR-20-0700
McLeod, Robert, et al. "First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,18 (2020): 4777-4784. doi: https://doi.org/10.1158/1078-0432.CCR-20-0700
McLeod R, Kumar R, Papadatos-Pastos D, Mateo J, Brown JS, Garces AHI, Ruddle R, Decordova S, Jueliger S, Ferraldeschi R, Maiques O, Sanz-Moreno V, Jones P, Traub S, Halbert G, Mellor S, Swales KE, Raynaud FI, Garrett MD, Banerji U. First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors. Clin Cancer Res. 2020 Sep 15;26(18):4777-4784. doi: 10.1158/1078-0432.CCR-20-0700. Epub 2020 Jul 02. PMID: 32616501; PMCID: PMC7611345.
Copy Download .nbib Format: NLM
Comparison of five-year clinical outcomes of 524 cemented and cementless medial unicompartmental knee replacements.

The Knee

Martin B, Rahman A, Jenkins C, Mohammad H, Barker K, Dodd C, Jackson W, Price A, Mellon S, Murray D.
PMID: 34883332
Knee. 2021 Dec 06;34:89-97. doi: 10.1016/j.knee.2021.08.015. Epub 2021 Dec 06.

AIM: To compare the outcomes of cemented and cementless Unicompartmental Knee Replacements (UKR) at 5 years after surgery.METHODS: 262 cemented and 262 cementless medial mobile-bearing UKR, implanted by four high-volume surgeons using identical indications and surgical techniques, were reviewed...

Cite
Martin B, Rahman A, Jenkins C, et al. Comparison of five-year clinical outcomes of 524 cemented and cementless medial unicompartmental knee replacements. Knee. 2021;34:89-97doi: 10.1016/j.knee.2021.08.015.
Martin, B., Rahman, A., Jenkins, C., Mohammad, H., Barker, K., Dodd, C., Jackson, W., Price, A., Mellon, S., & Murray, D. (2021). Comparison of five-year clinical outcomes of 524 cemented and cementless medial unicompartmental knee replacements. The Knee, 3489-97. https://doi.org/10.1016/j.knee.2021.08.015
Martin, Benjamin, et al. "Comparison of five-year clinical outcomes of 524 cemented and cementless medial unicompartmental knee replacements." The Knee vol. 34 (2021): 89-97. doi: https://doi.org/10.1016/j.knee.2021.08.015
Martin B, Rahman A, Jenkins C, Mohammad H, Barker K, Dodd C, Jackson W, Price A, Mellon S, Murray D. Comparison of five-year clinical outcomes of 524 cemented and cementless medial unicompartmental knee replacements. Knee. 2021 Dec 06;34:89-97. doi: 10.1016/j.knee.2021.08.015. Epub 2021 Dec 06. PMID: 34883332.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 196 entries